X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
humans (21) 21
female (20) 20
middle aged (17) 17
oncology (17) 17
breast neoplasms - drug therapy (16) 16
adult (15) 15
aged (15) 15
breast neoplasms - pathology (13) 13
breast cancer (12) 12
further section · weitere sektionen (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
cancer (8) 8
chemotherapy (8) 8
disease-free survival (7) 7
beer (6) 6
biochemistry (6) 6
breast neoplasms - surgery (6) 6
chemistry (6) 6
compositions or test papers therefor (6) 6
condition-responsive control in microbiological orenzymological processes (6) 6
enzymology (6) 6
measuring or testing processes involving enzymes, nucleicacids or microorganisms (6) 6
metallurgy (6) 6
microbiology (6) 6
mutation or genetic engineering (6) 6
processes of preparing such compositions (6) 6
prospective studies (6) 6
spirits (6) 6
vinegar (6) 6
wine (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
breast neoplasms - mortality (5) 5
cyclophosphamide - administration & dosage (5) 5
treatment outcome (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
carcinoma (4) 4
chemotherapy, adjuvant (4) 4
dose-response relationship, drug (4) 4
drug administration schedule (4) 4
epirubicin - administration & dosage (4) 4
neoadjuvant chemotherapy (4) 4
neoadjuvant therapy (4) 4
paclitaxel - administration & dosage (4) 4
prognosis (4) 4
risk factors (4) 4
therapy (4) 4
aged, 80 and over (3) 3
analysis (3) 3
breast neoplasms - metabolism (3) 3
combined modality therapy (3) 3
contents · inhalt (3) 3
cyclophosphamide (3) 3
doxorubicin (3) 3
doxorubicin - administration & dosage (3) 3
doxorubicin - adverse effects (3) 3
fluorouracil - administration & dosage (3) 3
follow-up (3) 3
granulocyte colony-stimulating factor (3) 3
granulocyte colony-stimulating factor - administration & dosage (3) 3
health aspects (3) 3
history (3) 3
immunohistochemistry (3) 3
kaplan-meier estimate (3) 3
medicine & public health (3) 3
multivariate analysis (3) 3
neoplasm metastasis (3) 3
obstetrics & gynecology (3) 3
preoperative chemotherapy (3) 3
proportional hazards models (3) 3
randomized-trial (3) 3
research (3) 3
taxoids - administration & dosage (3) 3
trastuzumab (3) 3
women (3) 3
adjuvant treatment (2) 2
anthracyclines (2) 2
antibiotics, antineoplastic - adverse effects (2) 2
austria (2) 2
breast conservation (2) 2
breast neoplasms - prevention & control (2) 2
cancer therapies (2) 2
carcinoma, ductal, breast - drug therapy (2) 2
chemotherapy, adjuvant - methods (2) 2
chi-square distribution (2) 2
clinical medicine (2) 2
clinical trials (2) 2
cmf (2) 2
diagnosis (2) 2
doxorubicin - therapeutic use (2) 2
expert discussion · expertenplenum (2) 2
further section (2) 2
germany (2) 2
hematology, oncology and palliative medicine (2) 2
hormone-therapy (2) 2
lymphatic metastasis (2) 2
mastectomy (2) 2
metastatic breast cancer (2) 2
methotrexate (2) 2
methotrexate - administration & dosage (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 18, pp. 1888 - 1896
IMPORTANCE: Standard dosing of chemotherapy based on body surface area results in marked interpatient variation in pharmacokinetics, toxic effects, and... 
MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | THERAPY | EUROPEAN-ORGANIZATION | CMF | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Austria | Sweden | Fluorouracil - administration & dosage | Antineoplastic Agents - adverse effects | Chemotherapy, Adjuvant - adverse effects | Adult | Female | Drug Administration Schedule | Neoplasm Recurrence, Local | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Quality of Life | Breast Neoplasms - mortality | Aged | Germany | Women | Chemotherapy | Usage | Adjuvant treatment | Clinical trials | Breast cancer | Diagnosis | Research | Comparative analysis | Health aspects | Cancer | Womens health | Risk factors | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Cancer, ISSN 0008-543X, 08/2006, Volume 107, Issue 4, pp. 883 - 883
Journal Article
Cancer, ISSN 0008-543X, 08/2006, Volume 107, Issue 4, pp. 883 - 883
Journal Article
Cancer, ISSN 0008-543X, 08/2006, Volume 107, Issue 4, p. 883
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, pp. e45826 - e45826
In our previous work we showed that NGAL, a protein involved in the regulation of proliferation and differentiation, is overexpressed in human breast cancer... 
GENE-EXPRESSION SIGNATURE | PREOPERATIVE CHEMOTHERAPY | GASTRIC-CANCER | CYCLOPHOSPHAMIDE | PROGNOSIS | III RANDOMIZED GEPARTRIO | MULTIDISCIPLINARY SCIENCES | DOXORUBICIN | SYSTEMIC THERAPY | DOCETAXEL | CARCINOMA | Lipocalins - metabolism | Proto-Oncogene Proteins - metabolism | Multivariate Analysis | Predictive Value of Tests | Receptors, Estrogen - metabolism | Prognosis | Acute-Phase Proteins - metabolism | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Receptor, ErbB-2 - metabolism | Treatment Outcome | Tissue Array Analysis - statistics & numerical data | Breast Neoplasms - drug therapy | Remission Induction | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Immunohistochemistry - statistics & numerical data | Breast Neoplasms - pathology | Lipocalin-2 | Adult | Female | Neoadjuvant Therapy | Immunohistochemistry | Breast cancer | Patient outcomes | Adjuvant treatment | Cancer | Staining | Multivariate analysis | Cancer therapies | Subgroups | Proteins | Breast carcinoma | Quality | Risk groups | Gynecology | Lipocalin | Neutrophils | Gelatinase | Gene expression | Patients | Survival | Obstetrics | Studies | Pathology | Chemotherapy | Medical prognosis | Breast | Cytoplasm | Tumors | Index Medicus | Clinical trials | Leukocytes (neutrophilic) | Hormones | Nodes | Polymerase chain reaction | Biopsy | Differentiation
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 11/2006, Volume 13, Issue 11, pp. 1434 - 1442
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2001, Volume 19, Issue 15, pp. 3506 - 3515
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2007, Volume 43, Issue 16, pp. 2351 - 2358
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.